D-0175-2021 Class III Terminated
FDA drug recall D-0175-2021 was initiated by US Compounding Inc on Nov 25, 2020 and is designated Class III. Reason for recall: Labelling: Missing label. The recall status is terminated (terminated Nov 5, 2021). Affected quantity: 1640 syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- Jan 6, 2021
- Initiation Date
- Nov 25, 2020
- Termination Date
- Nov 5, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1640 syringes
Product Description
Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only. US Compounding 1270 Don's Lane Conway, AR 72032 (800) 718-3588 NDC 62295-3324-05
Reason for Recall
Labelling: Missing label.
Distribution Pattern
Nationwide
Code Information
Lot: 20202109@3 BUD: 3/20/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0175-2021
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026